MedTrace Logo

Tubeless Strategy for Enhanced Recovery After Sublobar Resection

NCT07409129 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2026-02-13

No results posted yet for this study

Summary

This is a prospective, randomized controlled clinical trial conducted at a single center. The study aims to evaluate whether a "tubeless" strategy can enhance recovery for patients undergoing minimally invasive thoracoscopic sublobar resection (wedge or segment resection) for small lung nodules.

Participants will be randomly assigned to one of two groups:

* The experimental group will receive the "tubeless" strategy, which includes non-endotracheal intubation anesthesia (using a laryngeal mask) and no routine chest tube drainage after surgery.
* The control group will receive the traditional strategy, which includes double-lumen endotracheal intubation anesthesia and routine chest tube drainage.

The main goal is to compare the rate of achieving high-quality fast-track recovery at 24 hours after surgery between the two groups. This study will provide evidence on whether the tubeless approach can help patients recover faster and more comfortably without compromising safety.

Conditions

  • Pulmonary Nodules
  • Early Stage Lung Cancer (I and II)
  • Thoracoscopic Surgery
  • Sublobar Resection

Interventions

DEVICE

Chest Tube Drainage

Routine placement of a chest tube (18-22 Fr) with water-seal drainage postoperatively.

DEVICE

Double-lumen Endotracheal Tube

Double-lumen endotracheal intubation for one-lung ventilation under general anesthesia.

DEVICE

Laryngeal Mask Airway

Airway management using a laryngeal mask airway with spontaneous ventilation during thoracoscopic surgery.

DRUG

Thoracic Paravertebral Block with Local Anesthetic

Thoracic paravertebral block using local anesthetic (e.g., ropivacaine) for intraoperative and postoperative analgesia.

PROCEDURE

Non-intubated Anesthesia

General anesthesia with spontaneous ventilation without endotracheal intubation.

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-06-01
Completion
2026-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07409129 on ClinicalTrials.gov